Yaniv Lustig

Chaim Sheba Medical Center - Central Virology Laboratory

Ramat-Gan

Israel

  • Chaim Sheba Medical Center - Central Virology Laboratory

SCHOLARLY PAPERS

5

DOWNLOADS

1,448

TOTAL CITATIONS

15

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Decreased Infectivity Following BNT162b2 Vaccination

Number of pages: 28 Posted: 07 Apr 2021
Gili Regev-Yochay, Sharon Amit, Moriah Bergwerk, Marc Lipsitch, Eyal Leshem, Rebecca Kahn, Yaniv Lustig, Carmit Cohen, Ram Doolman, Arnona Ziv, Ilya Novikov, Carmit Rubin, Irena Gimpelevich, Amit Huppert, Galia Rahav, Arnon Afek and Yitshak Kreiss
Chaim Sheba Medical Center - Infection Prevention & Control Unit, Sheba Medical Center - Clinical Microbiology, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Harvard T.H. Chan School of Public Health - Center for Communicable Disease Dynamics, Chaim Sheba Medical Center - Infectious Disease Unit, Harvard T.H. Chan School of Public Health - Center for Communicable Disease Dynamics, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Chaim Sheba Medical Center - Laboratory Division, Chaim Sheba Medical Center - Bio-statistical and Bio-mathematical Unit, Chaim Sheba Medical Center - Gertner Institute for Epidemiology & Health Policy, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Chaim Sheba Medical Center - Gertner Institute for Epidemiology & Health Policy, Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Infectious Diseases Unit, Chaim Sheba Medical Center - General Management and Chaim Sheba Medical Center - General Management
Downloads 788 (65,115)
Citation 7

Abstract:

Loading...

2.

BNT162b2 Vaccine-Induced Immune Responses and Dynamics Vary Among Age Groups, Sex and Co-Morbidities: A Longitudinal Prospective Cohort Study

Number of pages: 25 Posted: 04 Mar 2021
Yaniv Lustig, Einav Sapir, Gili Regev-Yochay, Carmit Cohen, Ronen Fluss, Liraz Olmer, Victoria Indenbaum, Michal Mandelboim, Ram Doolman, Sharon Amit, Ella Mendelson, Arnona Ziv, Amit Huppert, Carmit Rubin, Laurence Freedman and Yitshak Kreiss
Chaim Sheba Medical Center - Central Virology Laboratory, Sackler Faculty of Medicine, Tel-Aviv University, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Chaim Sheba Medical Center - The Gertner Institute for Epidemiology & Health Policy Research, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Laboratory Division, Sheba Medical Center - Clinical Microbiology, Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Bio-statistical and Bio-mathematical Unit, Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Chaim Sheba Medical Center - The Gertner Institute for Epidemiology & Health Policy Research and Chaim Sheba Medical Center - General Management
Downloads 299 (207,288)
Citation 1

Abstract:

Loading...

3.

Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in People Living with HIV-1

Number of pages: 14 Posted: 20 Apr 2021
Itzchak Levy, Anat Wieder-Finesod, Vladyslav Litchevski, Asaf Biber, Victoria Indenbaum, Liraz Olmer, Amit Huppert, Orna Mor, May Goldstein, Einav Sapir, Tammy Hod, Carmit Cohen, Yaniv Lustig and Galia Rahav
Chaim Sheba Medical Center - Infectious Diseases Unit, Chaim Sheba Medical Center - Infectious Diseases Unit, Chaim Sheba Medical Center - Infectious Diseases Unit, Chaim Sheba Medical Center - Infectious Diseases Unit, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - The Gertner Institute for Epidemiology & Health Policy Research, Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center, Chaim Sheba Medical Center - Infectious Diseases Unit, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv University - Sackler Faculty of Medicine, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Chaim Sheba Medical Center - Central Virology Laboratory and Chaim Sheba Medical Center - Infectious Diseases Unit
Downloads 273 (227,576)
Citation 7

Abstract:

Loading...

4.

Correlates of Protection of BNT162b2 Against COVID-19 Infection and Intensity of Symptomatic Disease; the Israeli COVID-19 Family Study (ICoFS)

Number of pages: 45 Posted: 10 Oct 2022
Gili Regev-Yochay, Yaniv Lustig, Gili Joseph, Mayan Gilboa, Noam Barda, Ilana Gens, Victoria Indenbaum, Osnat Halpern, Shiri Katz-Likvornik, Tal Levin, Yara Kanaaneh, Keren Asraf, Sharon Amit, Carmit Rubin, Arnona Ziv, Ravit Koren, Michal Mandelboim, Noam H. Tokayer, Lilac Meltzer, Ram Doolman, Ella Mendelson, Sharon Alroy-Preis and Yitshak Kreiss
Chaim Sheba Medical Center - Infection Prevention & Control Unit, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Chaim Sheba Medical Center - ARC Innovation Center, Ministry of Health (Israel) - Public Health Services, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Dworman Automated-Mega Laboratory, Sheba Medical Center - Clinical Microbiology, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Chaim Sheba Medical Center - Data Management Unit, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Chaim Sheba Medical Center - Infection Prevention & Control Unit, Chaim Sheba Medical Center - Laboratory Division, Sheba Medical Center - Central Virology Laboratory, Ministry of Health (Israel) - Department of Maternal and Child Health and Chaim Sheba Medical Center - General Management
Downloads 69 (669,402)

Abstract:

Loading...

Correlates of protection, COVID-19, BNT162b2, IgG, neutralizing antibodies, T cell activity

5.

Robust Antibody Response after a Third BNT162b2 Vaccine Compared to the Second Among Immunocompromised and Healthy Individuals, a Prospective Longitudinal Cohort Study

Number of pages: 30 Posted: 19 Mar 2022
Shirley Shapiro Ben David, Barak Mizrahi, Daniella Rahamim-Cohen, Lia Supino-Rosin, Arnon Shahar, Sharon Hermoni-Alon, Ariela Fremder Sacerdote, Angela Irony, Rachel Lazar, Nir Kalkstein, Yaniv Lustig, Victoria Indenbaum, Daniel Landsberger, Miri Mizrahi-Reuveni and Shirley Shapira
Maccabi HealthCare Services, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, KI Research Institute, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Central Virology Laboratory, affiliation not provided to SSRN, Maccabi HealthCare Services and Maccabi HealthCare Services
Downloads 19 (1,059,597)

Abstract:

Loading...

BNT162b2 vaccine, COVID-19, humoral response, third vaccine dose, booster, immunocompromised